Fundraising FoxDexterabio
1 known investors
Find your way into Dexterabio
Dextera Biosciences develops dexabodies, a therapeutic modality built from D-amino acids that resists degradation by natural enzymes while retaining antibody-like specificity in a compact format, and can be conjugated to payloads such as steroids or toxins for targeted delivery. The company applies this synthetic D-protein platform to debilitating diseases with significant unmet medical need.
Founders & leadership
DS
Dev SidhuSAB Chair & Co-founder
GW
Gregory WentCEO & Chairman
KL
Kyle LandgrafVP of Discovery Research
AS
Andreea StuparuAssociate Director of Pharmacology
JW
Julia WilliamsSenior Director of Finance
SS
Severin SiggDirector of Discovery Chemistry
Investors · 1
Frequently asked questions
- What does Dexterabio do?
- Dextera Biosciences develops dexabodies, a therapeutic modality built from D-amino acids that resists degradation by natural enzymes while retaining antibody-like specificity in a compact format, and can be conjugated to payloads such as steroids or toxins for targeted delivery. The company applies this synthetic D-protein platform to debilitating diseases with significant unmet medical need.
- Who founded Dexterabio?
- Dexterabio was founded by Dev Sidhu.
- Who are Dexterabio's investors?
- Dexterabio's investors include BEVC.